Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study

Dov Shiffman; Daniel I. Chasman; Christie M. Ballantyne; Vijay Nambi; James J. Devlin; Eric Boerwinkle

doi:10.1160/TH09-01-0037

Thrombosis and Haemostasis, Table of Contents

Thromb Haemost 2009; 102(01): 179-180
DOI: 10.1160/TH09-01-0037

Letters to the Editor

Schattauer GmbH

Coronary heart disease risk, aspirin use, and apolipoprotein(a) 4399Met allele in the Atherosclerosis Risk in Communities (ARIC) study

Dov Shiffman

¹Celera, Alameda, California, USA

,

Daniel I. Chasman

²Center for Cardiovascular Disease Prevention, Division of Preventive Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Massachussetts, USA

,

Christie M. Ballantyne

³Section of Atherosclerosis and Vascular Medicine, Department of Medicine Baylor College of Medicine, and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA

,

Vijay Nambi

³Section of Atherosclerosis and Vascular Medicine, Department of Medicine Baylor College of Medicine, and Center for Cardiovascular Disease Prevention, Methodist DeBakey Heart and Vascular Center, Houston, Texas, USA

,

James J. Devlin

¹Celera, Alameda, California, USA

,

Eric Boerwinkle

⁴Human Genetics Center and Institute of Molecular Medicine, University of Texas, Houston Health Science Center, Houston, Texas, USA

› Author Affiliations

Abstract

Full Text

References

References
1 Luke MM, Kane JP, Liu DM. et al. A polymorphism in the protease-like domain of apolipoprotein(a) is associated with severe coronary artery disease. Arterioscler Thromb Vasc Biol 2007; 27: 2030-2036.
2 Shiffman D, Kane JP, Louie JZ. et al. Analysis of 17,576 potentially functional SNPs in three case-control studies of myocardial infarction. PLoS ONE 2008; 03: e2895.
3 Shiffman D, O’Meara ES, Bare LA. et al. Association of gene variants with incident myocardial infarction in the cardiovascular health study. Arterioscler Thromb Vasc Biol 2008; 28: 173-179.
4 Chasman DI, Shiffman D, Zee RYL. et al. Polymorphism in the apolipoprotein(a) gene, plasma lipoprotein(a), cardiovascular disease, and low-dose aspirin therapy. Atherosclerosis 2009; 203: 371-376.
5 Morrison AC, Bare LA, Chambless LE. et al. Prediction of coronary heart disease risk using a genetic risk score: the Atherosclerosis Risk in Communities Study. Am J Epidemiol 2007; 166: 28-35.